Redburn raised the price target for the Moderna Inc. (NASDAQ:MRNA) stock from ‘a Sell’ to ‘a Neutral’. The rating was released on February 01, 2023, according to finviz. The research report from BofA Securities has upgraded the stock from Underperform to Neutral, with a price target set at $180. The stock was initiated by UBS, who disclosed in a research note on January 21, 2023, to Neutral and set the price objective to $221. Sponsored
The latest trade, Performances and Moving Averages give us the following Picture
The share price of Moderna Inc.
Related Post
Iveda Solutions Inc. (NASDAQ:IVDA) stock is trading -90.88 percent below its 52-week high
The share price of Iveda Solutions Inc. (NASDAQ:IVDA) raised 33.83% to close Monday’s market session at $1.78, higher as compared to yesterday&#
27Is it possible to sustain this rally? Invitation Homes Inc. (INVH) Stock
Jefferies raised the price target for the Invitation Homes Inc. (NYSE:INVH) stock to ‘a Buy’. The rating was released on April 20, 2023, a
25Generac Holdings Inc. (GNRC) Stock is looking to regain its victory
Wells Fargo raised the price target for the Generac Holdings Inc. (NYSE:GNRC) stock to ‘an Overweight’. The rating was released on June 29
24Banco Bradesco (NYSE:BBDO) Sees Large Volume Increase
Banco Bradesco S.A. (NYSE:BBDO – Get Rating) shares saw strong trading volume on Friday . 2,882 shares traded hands during trading, a decline of 85% from the previous session’s volume of 19,364…
23National Fuel Gas Company (NYSE:NFG) Stock: Thought Concerns
BofA Securities raised the price target for the National Fuel Gas Company (NYSE:NFG) stock to ‘an Underperform’. The rating was released o
22Lightspeed Commerce (NYSE:LSPD) Sees Unusually-High Trading Volume
Shares of Lightspeed Commerce Inc. (NYSE:LSPD – Get Rating) saw unusually-strong trading volume on Monday . Approximately 29,700 shares changed hands during mid-day trading, a decline of 98% from the…
21